Argos Therapeutics (ARGS) Getting Somewhat Positive Media Coverage, Analysis FindsPor Fresco Pimienta Abr 21, 2017
Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 4.73, and a price to sales ratio of 2.36. This rating was issued on 2/23/17. State Street Corp now owns 177,494 shares of the biopharmaceutical company's stock worth $870,000 after buying an additional 18,625 shares in the last quarter. These analysts and investment firms use various valuation methods to decide a price target for a stock.
Argos Therapeutics, Inc (Argos) is an immuno-oncology company. Analyst's consensus target price is measured at $1.6000 for twelve month. The Return on Equity ratio of Argos Therapeutics, Inc.
Argos Therapeutics, Inc. (ARGS) has a market capitalization of 16.17 Million which suggests the company is a huge company further suggesting that the shares of Argos Therapeutics, Inc. The stock appeared $13.97 above its 52-week highs and is up 10.48% for the last five trades.
Maximum and minimum EPS estimate for the current quarter is projected at $-0.26 and $-0.39, respectively, according to 2 analysts. This scale runs from 1 to 5 where 1 represents Strong Buy and 5 represents Sell. Investors who are keeping close eye on the stock of Argos Therapeutics, Inc.
A number of analysts have commented on ARGS shares.
Argos Therapeutics Inc had its "hold" rating reiterated by analysts at Stifel Nicolaus. (NASDAQ:ARGS) highlighted upward shift of +53.3879% or +0.2088 points to $0.5999. The difference between Actual EPS and Estimated EPS was -0.01 Percent. Future earnings predictions are perhaps the most essential input when trying to value a company. Finally, Zacks Investment Research downgraded shares of Argos Therapeutics from a "buy" rating to a "hold" rating in a research report on Tuesday, February 7th. The company traded a volume of 12.56 million shares over average volume of 1.15 million shares. Over the same time span, the stock marked US$9.22 as its best level and the lowest price reached was US$0.31.
Moving average is significant analytical tool used to discover current price trends and the possibility for a change in an established trend. Company's distance from 20 day simple moving average is -21.46% and distance from 50-Day simple moving average is -78.15%. The Moving Average SMA50 is -64.99% while SMA200 is -85.54%. The return on equity ratio or ROE stands at 0 percent while most common profitability ratio return on investment (ROI) was -96.3 percent. The stock now shows its YTD (Year to Date) performance of -87.76 percent while its Weekly performance value is 75.92%. The Monthly and Yearly performances are -29.42 percent and -94.39 percent respectively.
ARGS has a 1-year high price of $ 13.46 and 1-year low price of $0.31.
The stock now has its Annual Dividend of $0 and an annual Dividend Yield of 0 Percent.
The company is expected to report earnings of $-0.33 a share for the next quarter.
También te puede interesar...
Minuto de silencio a futbolista vivo
Abr 21, 2017
Lo curioso es que Oliveira estaba en el terreno de juego listo para disputar el partido de la tercera fecha de la Copa Libertadores.
Jimena Moreno, ratificada en el Consejo Federal de Cultura
Abr 21, 2017
En la oportunidad se renovaron las autoridades de la junta ejecutiva del organismo, la que cuenta con una muy fuerte presencia de la Región Norte.
Study shows strawberries can inhibit spread of breast cancer
Abr 21, 2017
Researchers have found that women with breast cancer can be helped with social connections. And forest therapy has been shown to benefit treatment of women with breast cancer.